Menu Search
Equities

Athens Medical Center SA

IATR:ATH

Athens Medical Center SA

Actions
  • Price (EUR)1.69
  • Today's Change0.105 / 6.65%
  • Shares traded4.31k
  • 1 Year change+9.06%
  • Beta0.9317
Data delayed at least 20 minutes, as of Apr 19 2024 15:11 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Athens Medical Centre Commercial SA is a Greece-based company engaged in the provision of primary and secondary healthcare services. The Company is involved in the organization, management and modernization of hospitals in Greece and abroad, the development of special activities with the aim of promoting medical research and methods of treatment, the training and selection of executives and staff on behalf of the hospitals and the importation of medical tools, instruments, machinery and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. It operates seven clinics in Athens and suburbs, Trans-Balkan Medical Center in Thessaloniki, two medical centers in Romania, one in Cyprus and a number of diagnostic centers located throughout Greece.

  • Revenue in EUR (TTM)249.37m
  • Net income in EUR9.07m
  • Incorporated1983
  • Employees3.23k
  • Location
    Athens Medical Center SADistomou 5-7, MarousiATHINA 151 25GreeceGRC
  • Phone+30 2 106198100
  • Fax+30 2 106198555
  • Websitehttps://www.iatriko.gr/
More ▼

Institutional shareholders

3.20%Per cent of shares held by top holders
HolderShares% Held
EFG Bank AGas of 31 Dec 20222.78m3.20%
Data from 02 Apr 2024 - 02 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.